A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.